Back to Search VC Home Page
Venture Capital Search Engine
search over 1,000 Venture Capital related sites
Keywords about VC:  

MPM Capital

1.Abingworth - News   (100%):
News Oxagen Limited Raises $59.8 Million in Series B Private Venture Capital Financing Led by MPM Capital Abingdon, UK, 23 May 2005 - Oxagen Limited, a drug discovery and development company specializing in inflammation, announced today the successful completion of a $59.8 Million ( 31.6 Million) Se...
2.Beecken Petty & Company   (76%):
Recent News CryoCor Raises $12.0 Million to Accelerate Clinical Development - Financing to Secure Commercialization of Cryoablation Therapy For Irregular Heart Rhythms - SAN DIEGO, Jan. 28 /PRNewswire/ -- CryoCor, Inc., a development stage medical technology company, today announced that the Compan...
3.Domain Associates, LLC   (66%):
Kim P. Kamdar Associate Ms. Kamdar joined Domain Associates in January of 2005. Prior to joining Domain, Ms. Kamdar was a Kauffman Fellow at MPM Capital and has over 15 years experience in biotechnology. Prior to joining MPM, Ms. Kamdar was program leader for a drug discovery effort at the Torrey M...
4.Kaiser Permanente   (62%):
Alloy Ventures www.alloyventures.com Ascension Health Ventures www.ascensionhealthventures.org Bay City Capital www.baycitycapital.com CB Health Ventures www.cbhealthventures.com De Novo Ventures www.denovovc.com Delphi Ventures www.delphiventures.com Domain Ventures www.domainvc.com Draper Fisher V...
5.BA Venture Partners - News: Portfolio News   (57%):
BAVP News Portfolio News Events Somaxon files for IPO PE Week Wire: October 7th, 2005 Somaxon Pharmaceuticals Inc., a San Diego-based drug company focused on insomnia and other neuro-psychiatric disorders, has filed to raise $86.25 million via an IPO of common stock. It plans to trade on the Nasdaq ...
6.Acorda :: Current Investors   (42%):
Acorda Therapeutics is a privately held biotechnology company devoted to developing therapies for individuals with spinal cord injury, multiple sclerosis, and related disorders of the nervous system. Since its inception in 1995, Acorda has raised over $140 million through a combination of individua...
7.5AM Ventures - Company Profile   (38%):
October 12, 2005 DR. FLEMMING ORNSKOV NAMED PRESIDENT AND CHIEF EXECUTIVE OFFICER OF IKARIA, INC. September 7, 2005 GENOSPECTRA APPOINTS GEORGE E. BERS EXECUTIVE VICE PRESIDENT, COMMERCIAL OPERATIONS August 24, 2005 KALYPSYS ANNOUNCES KEY APPOINTMENT - DR. PAUL GRINT AS CHIEF MEDICAL OFFICER July 19...
8.Kodiak Venture Partners   (38%):
Dave Furneaux Lou Volpe John Abraham Chris Greendale Elliot Katzman Chip Meakem Mike Schiavo Murray Berkowitz Penny Breen Luciana Castro Steve Maxwell The Team Mike Schiavo General Partner & Chief Financial Officer Background: Mike has been active in private equity-related activities since 1983. Pri...
9.Lion Selection Group Limited - MPI Mines Limited   (38%):
Home Index Company Investments Allegiance Mining Austindo Resources Copperbelt Selection De Grey Mining Exco Resources Gallery Gold Havilah Resources Indophil Resources Lafayette Mining Leviathan Resources Sedimentary Holdings View Resources Westonia Mines Inv Summary Table Company Reports Investor ...
10.Venture capital alliances - syndicate firms from ARCH Venture Partners   (38%):
ARCH works with many other venture capital firms and institutional investors who serve as limited partners, co-investors, and sources of feedback for new company ideas. The following is a partial list of companies that have co-invested in ARCH portfolio companies as part of a syndicate. 3M Corporati...
11.CapitalVenue Massachusetts   (35%):
Venture Investors that have worked with CapitalVenue Home | Events | TeamVenue | Programs | "New" Newsletter | Contact us The following list of venture investors have participated in CapitalVenue's Past Events Adams Harkness and Hill Ventures Advanced Technology Program, NIST Advent Intern...
12.Flagship Ventures   (35%):
Flagship & Portfolio Company News Archives 2003 2002 GENPATH PHARMACEUTICALS BECOMES AVEO PHARMACEUTICALS Cambridge, MA, March 1, 2005 GenPath Pharmaceuticals, Inc., a drug discovery and development company focused on the treatment of cancer and other diseases, announced today that it has changed it...
13.Abingworth - News   (34%):
News Abingworth appoints David Pinniger London, 21 September 2005 - Abingworth Management, the life sciences investment group, has appointed David Pinniger, CFA as a Principal, Analyst. He will focus on evaluating new and existing investment opportunities in public life science companies in Abingwor...
14.Abingworth - News   (34%):
News Abingworth appoints David Pinniger London, 21 September 2005 - Abingworth Management, the life sciences investment group, has appointed David Pinniger, CFA as a Principal, Analyst. He will focus on evaluating new and existing investment opportunities in public life science companies in Abingwor...
15.BA Venture Partners - News: Portfolio News   (33%):
BAVP News Portfolio News Events Somaxon Files IPO To Raise Up To $86.25M In Common Stock By VentureWire Staff Reporters VenutreWire: October 10th, 2005 Psychiatric drug developer Somaxon Pharmaceuticals Inc. Friday filed for an initial public offering to sell up to $86.25 million in common stock, in...
16.Acorda :: Board of Directors   (30%):
Ron Cohen, M.D. Standish M. Fleming, Forward Ventures John Friedman, Easton Hunt Capital Partners Sandra Panem, Ph.D., Cross Atlantic Partners Barclay Phillips, Vector Fund Management Mark R. E. Pinney, M.B.A., C.F.A., M.Sc. Steven M. Rauscher, Oscient Pharmaceuticals Michael Steinmetz, Ph.D., MPM ...
17.Apax Partners - Healthcare Sector   (30%):
Apax Partners Registered Users Sitemap Contact Us Legal Home Sector Focus Tech & Telecom Team Investments Knowledge Retail & Consumer Team Investments Knowledge Media Team Investments Knowledge Healthcare Team Investments Knowledge Financial & Business Services Team Investments Knowledge Our Company...
18.Apax Partners - Knowledge   (30%):
Apax Partners Registered Users Sitemap Contact Us Legal Home Sector Focus Tech & Telecom Team Investments Knowledge Retail & Consumer Team Investments Knowledge Media Team Investments Knowledge Healthcare Team Investments Knowledge Financial & Business Services Team Investments Knowledge Our Company...
19.GreenHills Ventures   (22%):
Investors: Login | Businesses: Submit Plan GreenHills Ventures, LLC., combines extensive advisory experience with strategic initiatives. We focus on providing strong fundamentals to facilitate sound business execution. GreenHills Ventures, LLC., has developed an extensive network of Fortune 1000 co...
20.National Venture Capital Association   (21%):
HOME 2005 NVCA Annual Meeting Waldorf=Astoria Hotel New York, NY May 4-5, 2005 The NVCA Annual Meeting is open to all venture capital and private equity professionals. NVCA reserves the right to decline any registrations from individuals who do not meet this criteria. Agenda | Registration | Hotel I...

Page: 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20  

VC Directory: A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z   Others